Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023
02 Outubro 2023 - 8:30AM
Business Wire
Apyx® Medical Corporation (NASDAQ:APYX) (the “Company”),
the manufacturer of a proprietary helium plasma and radiofrequency
technology marketed and sold as Renuvion®, today announced that
financial results for the third quarter of fiscal year 2023 will be
released before the market opens on Thursday, November 9th.
Management will host a conference call at 8:00 a.m. Eastern Time
on November 9th to discuss the results of the quarter, and to host
a question and answer session. To listen to the call by phone,
interested parties may dial 877-407-8289 (or 201-689-8341 for
international callers) and provide access code 13741467.
Participants should ask for the Apyx Medical Corporation Call. A
live webcast of the call will be accessible via the Investor
Relations section of the Company’s website and at:
https://event.choruscall.com/mediaframe/webcast.html?webcastid=wXKixaYt
A telephonic replay will be available approximately three hours
after the call ends through the following two weeks. The replay can
be accessed by dialing 877-660-6853 for U.S. callers or
201-612-7415 for international callers and using the replay access
code: 13741467. The webcast will be archived on the Investor
Relations section of the Company’s website.
About Apyx Medical
Corporation: Apyx Medical Corporation is an advanced
energy technology company with a passion for elevating people’s
lives through innovative products, including its Helium Plasma
Technology products marketed and sold as Renuvion in the cosmetic
surgery market and J-Plasma® in the hospital surgical market.
Renuvion and J-Plasma offer surgeons a unique ability to provide
controlled heat to tissue to achieve their desired results. The
Company also leverages its deep expertise and decades of experience
in unique waveforms through OEM agreements with other medical
device manufacturers. For further information about the Company and
its products, please refer to the Apyx Medical Corporation website
at www.ApyxMedical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231002521458/en/
Investor Relations: ICR
Westwicke on behalf of Apyx Medical Corporation Mike Piccinino, CFA
investor.relations@apyxmedical.com
Apyx Medical (NASDAQ:APYX)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Apyx Medical (NASDAQ:APYX)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024